Abstract Decision: Authors will be notified of acceptance or rejection via e-mail by June 30th 2016. If you would like to apply for MERIT AWARD, submit your abstract by May 15th, 2016. If you need early abstract decisions for visa or other purposes, please submit your abstract to ICAHO 2016 conference by April 15th, 2016..

We will accept hematology and oncology related abstracts in the following categories:

1. Basic science research

2. Clinical research

3. Case reports

General guidelines

Abstracts submitted should not have been previously published or presented at another meeting.

Abstracts must be written in the format provided. Click here to download the abstract template.

Abstracts should be no more than 300 words (excluding abstract title, authors and affiliations).

Abstracts should be written in English.

For both primary and co-authors, credentials along with their full first and last names and email addresses must be included. If co-authors are from different institutions, the secondary institution(s) and the institution investigators are associated with must be listed using a superscript.

The Binayara Foundation will provide merit award to up to ten presenters to present their abstracts at the 4th International Conference on Advances in Hematology and Oncology (ICAHO 2016). An author who is either a medical student, graduate student, resident physician, post-doctoral fellow (MD or PhD), or a junior faculty in practice for less than 3 years is eligible to apply for the merit award. In order to qualify for the award, the applicant must be first or senior author and presenter of the selected abstract.

Only abstracts submitted by May 15, 2016 will be considered for the merit award.

The merit award recipients will receive $500 for travel assistance, and complimentary registration to the conference.

Abstracts presented at the International Conference on Advances in Hematology and Oncology (ICAHO 2015) were published in Anticancer Research Journal. Click here to view the published abstracts.

Conference CME Information

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Ada Canyon Medical Education Consortium and the Binaytara Foundation. The Ada Canyon Medical Education Consortium is accredited by the Idaho Medical Association and the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Ada Canyon Medical Education Consortium designates this live activity for a maximum of 14.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Bonus CME

"Biologic Therapies and the role of Biosimilars in Oncology"
Saturday, August 13th, 2016 (5:30 PM - 6:30 PM)
This program is not part of the 4th International Conference on Advances in Hematology and Oncology (ICAHO 2016). This is a side program provided by The France Foundation at no additional cost to the attendees of ICAHO 2016.
Sign up sheet available at the registration desk.

Invitation to submit abstract

Abstracts presented at the ICAHO 2016 will be published in the ANTICANCER RESEARCH journal.
Click here to view the abstracts presented during last year's conference - ICAHO 2015.
Click here to learn more.

Binaytara Foundation

The Binaytara Foundation (BTF) is an Illinois non-profit organization exempt from taxation pursuant to Section 501(c)(3) of the Internal Revenue Code. The mission of BTF is to bring positive changes in our communities by promoting health and education.